1 / 8

Neurological Therapeutics - “Diagnose and Adios” No More

Neurological Therapeutics - “Diagnose and Adios” No More. Dr. Norman Delanty Consultant Neurologist Beaumont Hospital, Dublin Neurology Update Meeting, October 24, 2008. The Role of the Doctor. Providing explanation Reducing uncertainty Giving reassurance Improving quality of life

Download Presentation

Neurological Therapeutics - “Diagnose and Adios” No More

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Neurological Therapeutics - “Diagnose and Adios” No More Dr. Norman Delanty Consultant Neurologist Beaumont Hospital, Dublin Neurology Update Meeting, October 24, 2008

  2. The Role of the Doctor • Providing explanation • Reducing uncertainty • Giving reassurance • Improving quality of life • Reducing suffering / pain • Prolonging life

  3. The Past • Neurologists were seen as astute diagnosticians • Great at “chin-scratching” • Not much good at making a real difference to people’s lives • Once diagnosis made, often no treatments to offer, and often no great need or point to continue to see patients on regular and frequent follow up

  4. The Present • Diagnostic capability improving, e.g., • Imaging • Neurogenetics • Video EEG monitoring • Treatment modalities expanding • Advances in classical pharmacology • Biological therapies • Non-pharmacological approaches

  5. The Future • Further understanding of neurobiology of disease • Whole genome analysis of large number of patients with well phenotyped neurological conditions • New biological pathways • Pharmacogenomics • New targeted “biologicals”

  6. Resources • Neurology remains the Cinderella of the medical specialties • Particularly so in Ireland • Little central planning for advances in therapeutics • E.g., natalizumab • No concept of “investing to save” in the Irish system

  7. PubMed • Neurologocal therapeutics - 20,535 • Treatments for neurological disease - 257,024 • Treatments of Parkinson’s disease - 7,789 • Antiepileptic drugs - 132,404 • Natalizumab - 345 • Lacosamide - 43

  8. Today • Alzheimer’s disease - Colin Doherty • Stroke - Mark McCarron • Migraine - Peter Boers • Anti-epileptic drugs - Kevin Murphy • Multiple sclerosis - Joan Moroney • Parkinson’s disease - Tim Counihan • Psychiatric disease in neurology - David Cotter • Mitochondrial disease - Doug Turnbull

More Related